Botox Approval History
FDA Approved: Yes (First approved December 9, 1991)
Brand name: Botox
Generic name: onabotulinumtoxinA
Dosage form: Injection
Company: Allergan plc
Treatment for: Chronic Spasticity, Hyperhidrosis, Cervical Dystonia, Migraine, Urinary Incontinence
Botox (onabotulinumtoxinA) is a neurotoxin complex indicated for the treatment of cervical dystonia, severe primary axillary hyperhidrosis (underam sweating), upper limb spasticity, lower limb spasticity, prevention of chronic migraine, urinary incontinence in people with neurologic conditions, and overactive bladder.
Development History and FDA Approval Process for Botox
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.